Drug-Eluting Balloon in Peripheral Intervention for Below the Knee Angioplasty Evaluation (DEBATE-BTK) | Zendy

Francesco Liïstro | Zendy; Italo Porto | Zendy; Paolo Angioli | Zendy; Simone Grotti | Zendy; Lucia RicciVitiani | Zendy; Kenneth Ducci | Zendy; Giovanni Falsini | Zendy; Giorgio Ventoruzzo | Zendy; Filippo Turini | Zendy; Guido Bellandi | Zendy; Leonardo Bolognese | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Drug-Eluting Balloon in Peripheral Intervention for Below the Knee Angioplasty Evaluation (DEBATE-BTK)

Author(s) -

Francesco Liïstro,

Italo Porto,

Paolo Angioli,

Simone Grotti,

Lucia RicciVitiani,

Kenneth Ducci,

Giovanni Falsini,

Giorgio Ventoruzzo,

Filippo Turini,

Guido Bellandi,

Leonardo Bolognese

Publication year - 2013

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.113.001811

Subject(s) - medicine , angioplasty , balloon , drug , peripheral , bruton's tyrosine kinase , intervention (counseling) , cardiology , pharmacology , psychiatry , receptor , tyrosine kinase

The 1-year restenosis rate after balloon angioplasty of long lesions in below-the-knee arteries may be as high as 70%. Our aim was to investigate the efficacy of a paclitaxel drug-eluting balloons versus conventional percutaneous transluminal angioplasty (PTA) for the reduction of restenosis in diabetic patients with critical limb ischemia undergoing endovascular intervention of below-the-knee arteries.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research